- Home
- KMDA vs AVNW Comparison
KMDA vs AVNW Comparison
Compare KMDA & AVNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KMDA
- AVNW
- Stock Information
- Founded
- KMDA 1990
- AVNW 2006
- Country
- KMDA Israel
- AVNW United States
- Employees
- KMDA N/A
- AVNW N/A
- Industry
- KMDA Biotechnology: Pharmaceutical Preparations
- AVNW Radio And Television Broadcasting And Communications Equipment
- Sector
- KMDA Health Care
- AVNW Technology
- Exchange
- KMDA Nasdaq
- AVNW Nasdaq
- Market Cap
- KMDA 394.4M
- AVNW 241.8M
- IPO Year
- KMDA N/A
- AVNW 2007
- Fundamental
- Price
- KMDA $6.92
- AVNW $20.68
- Analyst Decision
- KMDA Strong Buy
- AVNW Strong Buy
- Analyst Count
- KMDA 2
- AVNW 5
- Target Price
- KMDA $14.50
- AVNW $38.60
- AVG Volume (30 Days)
- KMDA 159.8K
- AVNW 140.3K
- Earning Date
- KMDA 03-05-2025
- AVNW 02-11-2025
- Dividend Yield
- KMDA N/A
- AVNW N/A
- EPS Growth
- KMDA 124.29
- AVNW N/A
- EPS
- KMDA 0.27
- AVNW N/A
- Revenue
- KMDA $158,380,000.00
- AVNW $409,603,000.00
- Revenue This Year
- KMDA $15.37
- AVNW $9.06
- Revenue Next Year
- KMDA $8.58
- AVNW $7.87
- P/E Ratio
- KMDA $25.36
- AVNW N/A
- Revenue Growth
- KMDA 4.52
- AVNW 17.00
- 52 Week Low
- KMDA $4.74
- AVNW $12.96
- 52 Week High
- KMDA $8.00
- AVNW $38.85
- Technical
- Relative Strength Index (RSI)
- KMDA 50.80
- AVNW 60.33
- Support Level
- KMDA $6.90
- AVNW $17.91
- Resistance Level
- KMDA $7.56
- AVNW $19.73
- Average True Range (ATR)
- KMDA 0.19
- AVNW 0.83
- MACD
- KMDA -0.09
- AVNW -0.04
- Stochastic Oscillator
- KMDA 15.95
- AVNW 81.59
About KMDA Kamada Ltd.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, Proprietary Products segment and Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
About AVNW Aviat Networks Inc.
Aviat Networks Inc is a networking solutions provider. It designs, manufactures and sells wireless networking products, solutions, and services to mobile and fixed operators, private network operators, government agencies, transportation and utility companies, public safety agencies, and broadcast network operators around the world. The company's product categories include point-to-point microwave and millimeter wave radios that are licensed (subject to local frequency regulatory requirements), lightly licensed and license-exempt (operating in license-exempt frequencies), and element and network management software.